BrosMed received CE mark approval for Pronavi™ Microcatheter
Release time:
2021-05-26
Sittard, Netherlands [May 26, 2021] –BrosMed received CE Mark approval in the European Union for its Pronavi™ Microcatheter. This device is indicated for use in both coronary and peripheral interventions.
Sittard, Netherlands [May 26, 2021] –BrosMed received CE Mark approval in the European Union for its Pronavi™ Microcatheter. This device is indicated for use in both coronary and peripheral interventions.
Microcatheters are used to provide support and safe guidewire exchange during complex cardiovascular procedures. The Pronavi™ Microcatheter facilitates excellent guidewire support, guidewire exchange and focal delivery of contrast media into coronary arteries, peripheral and abdominal vascular systems during complex endovascular procedures.
The Pronavi™ microcatheter has two kinds of distal tip design – a 1.7Fr & 1.9 Fr. The Pronavi™ 1.7Fr, has a proprietary hydrophilic coating and flexible distal segment to enable advancement and access through distal tortuous vessels. The shaft is fully stainless-steel braided for responsiveness, lumen integrity, and pushability. The radiopaque tapered soft 1.9Fr tip provides exceptional durability and pushability through tight calcified lesions and interstitial branches.
Pronavi™ is 0.014” guidewire compatible and available in 135cm, 150cm and 162cm lengths, with 6 configurations in total for antegrade and retrograde access. The 135 cm working length is used for antegrade; 150 cm and 162cm for retrograde.
“We are delighted to expand our CTO portfolio to include microcatheters for complex coronary and peripheral interventions.”said David Camp Business development VP of BrosMed. “We are committed to delivering innovative products that can change the lives of patients and their families around the world and to provide our physician partners with a greater flexibility and treatment options for patients.”
About BrosMed Medical
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
